Starting at high doses significantly increases nausea, vomiting, and gastrointestinal side effects that often lead to treatment discontinuation
The primary outcome was the prevalence of confirmed clinical neuropathy assessed by nerve conduction studies of the median, peroneal motor, and sural sensory nerves with a standard protocol
A peptide with reduced acidity was designed for increased cell permeability The p53 TAD2 sequence exhibited a highly negative charge, whereas the p53 binding interface of the FOXO4 FHD contains several positively charged residues
For teens who are age and weight eligible, whose physician supports the decision, and who are booked with a properly vetted provider, IV therapy can be a responsible and effective option
States with full NP practice authority (like Illinois after meeting requirements, or Californias new 104 NP pathway) allow independent prescribing